ClexBio is a preclinical-stage regenerative medicine company with a breakthrough platform for scalable, high-throughput generation of therapeutic tissues. We represent the next generation of cell therapy leveraging fully functional bioengineered tissues to powerfully elevate the restorative ability of cells and produce a new class of curative treatments for some of the world's most challenging medical conditions.
| Website | http://www.clexbio.com |
| Employees | 7 (3 on RocketReach) |
| Technologies |
JavaScript
,
HTML
,
Twitter
+8 more
(view full list)
|
| Industry | Biotechnology |
| Keywords | Clinical Trials, Regenerative Medicine, Advanced Therapy, Cell Therapy, Preclinical Stage, High Throughput, Scalable Production, Tissue Engineering, Cell Manufacturing, Biotechnology, Drug Development, Pharmaceutical, Medical Technology, Life Sciences, Bioprocessing, Healthcare, Biopharma |
| Competitors | Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, QIAGEN, BioRender, Roche, PerkinElmer, Inc., MilliporeSigma, Sartorius +43 more (view full list) |
Looking for a particular ClexBio employee's phone or email?
Armend Håti is the CEO and Co-founder of ClexBio.
3 people are employed at ClexBio.
ClexBio is based in Lewes, Delaware.